MAPT and Alzheimer disease: Based on these results, it is suggested that deficiency of GLUT1 and GLUT3 in AD may impair brain glucose uptake/metabolism, causing neurodegeneration by the downregulation of O-GlcNAcylation and hyperphosphorylation of tau [207,210,211].